/news/b/pressreleases/archive/2013/01/30/neuromax-a-skolkovo-resident-company-successfully-completes-first-phase-of-clinical-trials-for-diabetic-neuropathy-drug.aspxNeuroMax has successfully completed Phase Ia clinical trials on the safety and pharmacokinetics of drug candidate NM-IA-001 (BNV-222) for patients with diabetic neuropathy. Previously approved by the Ministry of Health of the Russian Federation the study7.x Production